Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus
The relationship between obesity and mortality rate among diabetic patients is a controversial topic. The aim of this study was to investigate the association between obesity and all-cause mortality risk in patients with type 2 diabetes.
In this retrospective database study, 2383 patients with type 2 diabetes, who had been registered in the Isfahan Endocrine and Metabolism Research Center, Iran, were enrolled between 1992 and 2010. The mean (SD) of diabetes duration and follow-up period was 15.5 (8.0) and 7.8 (3.9) years. The main outcome was all-cause mortality. All-cause mortality rates were calculated for the body mass index (BMI) categories of underweight, normal, overweight and class I, II and III obese. Cox proportional hazard models were used to estimate the adjusted hazard ratio for BMI as categorical variable using BMI of 18.5–24.9 kg/m2 as the reference group.
The mortality rate in patients with normal weight was higher than overweight patients (59.11 vs. 33.17 per 1000 person-years). The adjusted hazard ratios of all-cause mortality were 0.82 [95%CI 0.68–0.99; P = 0.037], 0.79 [95%CI 0.61–1.02; P = 0.069], 0.71 [95%CI 0.42–1.19; P = 0.191] and 1.36 [95%CI 0.55–3.33; P = 0.507] for overweight, class I, II and III obesity, respectively. When BMI was included in the Cox model as a time-dependent variable, the U-shaped relationship between BMI and all-cause mortality did not change.
The results show a U-shaped association of BMI with all-cause mortality in patients with type 2 diabetes with the lowest risk observed among the overweight patients.
KeywordsMortality Diabetes mellitus Body mass index Obesity Death Overweight
We would like to thank Mr. Majid Abyar for technical computer assistance and all the patients for participation in this study.
Dr. Rezvan Salehidoost designed the study, wrote the manuscript and contributed to discussion. Dr. Asieh Mansouri contributed to the statistical analysis and interpretation of data. Prof. Massoud Amini contributed to conducting the research, interpreting the data and reviewed the manuscript. Dr. Sima Aminorroaya contributed to writing the manuscript and discussion. Prof. Ashraf Aminorroaya contributed to conducting the research, interpreting the data and reviewed the manuscript.
The study was funded by Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Isfahan University of Medical Sciences.
Informed consent was obtained from all patients for precipitation and registration.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
- 1.International Diabetes Federation (2015) IDF diabetes atlas eB. International Diabetes Federation, BelgiumGoogle Scholar
- 9.Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ (2016) BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. Bmj 353:i2156. https://doi.org/10.1136/bmj.i2156 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjornsdottir S, Eliasson B (2009) Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52(1):65–73. https://doi.org/10.1007/s00125-008-1190-x CrossRefPubMedGoogle Scholar
- 13.Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308(6):581–590. https://doi.org/10.1001/jama.2012.9282 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, Philip S, Wild S, Sattar N, Scottish Diabetes Research Network Epidemiology G (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36(4):887–893. https://doi.org/10.2337/dc12-0944 CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G (2014) Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation 130(24):2143–2151. https://doi.org/10.1161/circulationaha.114.009098 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Kwon Y, Kim HJ, Park S, Park YG, Cho KH (2017) Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis. PLoS ONE 12(1):e0168247. https://doi.org/10.1371/journal.pone.0168247 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, Saadat M, Esfahani EN, Ganji M, Noshad S, Khajeh E, Ghajar A, Heidari B, Afarideh M, Mechanick JI, Ismail-Beigi F (2017) Diabetes in Iran: prospective analysis from first nationwide diabetes report of national program for prevention and control of diabetes (NPPCD-2016). Sci Rep 7(1):13461. https://doi.org/10.1038/s41598-017-13379-z CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Statistical C, Of Iran (2011) Selected finding of the 2011 national population and housing census. https://www.amar.org.ir/Portals/1/Iran/census-2.pdf
- 21.American Diabetes Association (2000) Screening for type 2 diabetes. Diabetes Care 23(Suppl 1):S20–S23Google Scholar
- 22.Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, Reviewers of the AACEOCPG (2016) American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 22(Suppl 3):1–203. https://doi.org/10.4158/EP161365.GL Google Scholar
- 27.Zaccardi F, Dhalwani NN, Papamargaritis D, Webb DR, Murphy GJ, Davies MJ, Khunti K (2017) Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies. Diabetologia 60:240–248. https://doi.org/10.1007/s00125-016-4162-6 CrossRefPubMedGoogle Scholar
- 30.Tseng CH (2013) Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis 226(1):186–192. https://doi.org/10.1016/j.atherosclerosis.2012.09.004 CrossRefPubMedGoogle Scholar
- 32.Fadini GP, Boscaro E, de Kreutzenberg S, Agostini C, Seeger F, Dimmeler S, Zeiher A, Tiengo A, Avogaro A (2010) Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 33(5):1097–1102. https://doi.org/10.2337/dc09-1999 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Song X, Jousilahti P, Stehouwer CD, Soderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q (2015) Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans. Nutr Metab Cardiovasc Dis NMCD 25(3):295–304. https://doi.org/10.1016/j.numecd.2014.09.004 CrossRefPubMedGoogle Scholar
- 35.Schenkeveld L, Magro M, Oemrawsingh RM, Lenzen M, de Jaegere P, van Geuns RJ, Serruys PW, van Domburg RT (2012) The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open 2:e000535. https://doi.org/10.1136/bmjopen-2011-000535 CrossRefPubMedPubMedCentralGoogle Scholar